Hepion Pharmaceuticals to Present at NASH-TAG 2024 : vimarsa

EDISON, N.J., Jan. 03, 2024 -- Hepion Pharmaceuticals, Inc. , a clinical stage biopharmaceutical company focused on Artificial Intelligence -driven therapeutic drug development for the treatment of...

Related Keywords

Utah , United States , Park City , , Drug Administration , Globenewswire Inc , Hepion Pharmaceuticals Investor Relations , Nasdaq , Hepion Pharmaceuticals , Hepion Pharmaceuticals Inc , Artificial Intelligence , Hepatic Functional Improvement Detected , Hepquant Duo , Fast Track , Orphan Drug ,